Supporting equitable access to legal and regulated psychedelic medicine for all Canadians.

ABOUT OUR WORK

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. 

LATEST AT MAPS CANADA

June 19, 2025

MAPS Canada presents:

Expanding Minds on Post-Secondary Campuses: How Students Who Use Drugs are Reducing their Risk of Harm

Thurs, June 19th 7pm EST / 4pm PST

Around the world, youth and young adults engage in substance use for various reasons, including experimentation, socialization, performance enhancement, and to care for their wellbeing. This population includes post-secondary students; in the post-secondary environment, researchers have found that young adults are more likely to increase their substance use and their role in supplying substances. Post-secondary environments also house cutting-edge technology that can be used to identify ingredients in unregulated substances, preventing harm from unexpected contaminants and adulterants amidst the evolving drug supply. In this talk, Lauren will discuss the background and context of the student-run harm reduction team she co-founded and coordinated. She will share about engagement with the student community, including how students are using classroom knowledge to enhance their psychedelic journeys. Additionally, she will highlight what was shared by participants in an implementation science study of the harm reduction team’s on-campus drug checking service including how decision makers, service providers, and students navigated tensions in this political environment. Speaker Bio: Lauren is a registered nurse with a PhD in nursing from the University of British Columbia. For her PhD, she conducted an implementation science study of a multisector (university – community – health authority) student-run harm reduction drug checking service that she co-founded and coordinated. Presently she is conducting research to build robust harm reduction experiential education frameworks for post-secondary students. She is passionate about re-distributing resources from resource-rich institutions to address public health concerns.

June 12, 2025

MAPS Canada presents:

Psychedelic Safety - Drugs and Hugs: Drug Checking at Electronic Music Festivals in British Columbia

Thurs, June 12th 7pm EST / 4pm PST

Join Antoine Marcheterre and Jarred Aasen as they share their experience and knowledge providing drug checking service at two of the largest music festivals in British Columbia.   Drug checking data from these events provides a unique insight into the types of drugs that are used by many of the attendees.   The presenters will introduce what the current services offer through a user perspective, breakdown last year’s results and discuss the potential public health impacts of drug checking services in isolated meso-environments. The information presented in this webinar is supported by drug checking data from  2024 Festival Infographic – Interior Health Drug Checking.

May 23, 2025

MAPS Canada presents:

Serotonin, Spirituality & Science: Inside Psychedelics A to Z with Dr Olga Chernoloz

Join us for an insightful conversation with neuropharmacologist and author Dr. Olga Chernoloz as she breaks down the science, culture, and creativity woven into her beautifully illustrated book, Psychedelics A to Z. We explore key topics like harm reduction, microdosing, cultural use of cannabis, the role of music in transcendental states, and why journaling is essential for integration.

June 3rd, 2025

MAPS Canada presents:

Do Clinical Trials Provide Reasonable Access to Psychedelic Therapy?

Tues, June 3rd 7pm EST / 4pm PST

This webinar highlights perspectives of researchers, clinicians and patients across Canada on clinical trials as a pathway to access psychedelic therapy.

Since the introduction of psilocybin and MDMA to the Special Access Program (SAP) in 2022, there have been many questions of whether this access program is appropriate for psychedelic therapy.

Are clinical trials a better option? What challenges, barriers, opportunities and benefits arise from this pathway?

This webinar will also explore funding options and the development of a MAPS Canada working group for clinical research development.


Panelists:

Dr. Emma Hapke, MD, FRCPC, psychiatrist, psychotherapist and psychedelic researcher at the University Health Network in Toronto

Sonia Brodie, neuroscientist, Director of Growth & Partnerships at CaRe Clinics, and sits on the board of MAPS Canada as Director of Research

Pedram Dara, former MDMA-assisted therapy clinical trial participant and director of Psychedelic Lived Experiences

Melanie Dignam, MSW, RSW, integrative psychotherapist, clinical trial therapist

Host:
Erin Prosk, MSC, President and Co-founder Santé Cannabis

MAPS Canada's School of Psychedelics presents:

An Introduction to Cannabis and Psychedelics in Canada

Wed, May 21st 7pm EST / 4pm PST

Join us on May 21st!

We are bringing together a panel of experts who have extensive and varied personal and professional experiences with and perspectives about cannabis and psychedelics in Canada.

This webinar features some of the instructors of the MAPS Canada School of Psychedelics newest courses “Cannabis and Psychedelics: From Conceptualization to Care in Canada”.

These courses consider the similarities and differences between cannabis and psychedelics, exploring whether cannabis is a psychedelic substance, why that matters, and to whom.

Bonus: Attendees will receive a code for 50% off the courses!

MAPS Canada's School of Psychedelics presents:

Cannabis and Psychedelics: From Conceptualization to Care in Canada

From shifting laws to evolving therapeutic uses, the line between cannabis and psychedelics is more blurred than ever. This course explores where they align—and where they diverge.

Now open for registration!

Full Course Bundle includes 3 courses:
Course 1: Conceptualizations and Communities
Course 2: Mechanisms of Action, Clinical Research, Therapeutic Applications
Course 3: Legal Landscape and Policy Pathways

June 16-20, 2025

MAPS presents:

Psychedelic Science 2025

June 16 - 20

We are getting excited for Psychedelic Science 2025: The Integration!

Happening June 16–20 at the Colorado Convention Center in Denver. This is more than a conference—it’s a collective moment to come together, connect across disciplines, and shape the future of psychedelic science and healing.

And we want to you to join us!

Use our promo code for 15% off your registration: MAPSC15

Be part of a historic gathering where The Integration becomes real

May 8, 2025

MAPS Canada Research Room presents:

Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence

Thurs, May 8th 7pm EST / 4pm PST

Dr. Houman Farzin is a physician and researcher specializing in psychedelic medicine and palliative care. He serves as an attending physician in the Division of Palliative Care at the Jewish General Hospital and is a lecturer at McGill University. He is a trainer for Therapsil and was a former trial site physician for MAPPUSX, a multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD. He is the founder of Mystic Health, a psychedelic venture currently operating in Southern California. Additionally, he is a DJ and music producer with various international appearances. Talk Abstract: In this talk, the speaker will explore the role of music and silence in Psilocybin-assisted psychotherapy (PAP). While music is commonly used to guide therapeutic experiences, its absence has been under-explored. The talk will highlight findings from a study with two breast cancer patients in Canada’s compassionate access program, and other experiences conducting PAP. One patient found the silence helpful for mindfulness, while the other used it to explore challenging memories triggered by the music. These results suggest that silent periods in PAP can enhance mindfulness and therapist-patient interactions.

April 24, 2025

MAPS Canada presents:

Cannabis, Opioid Use Disorder & Overdose Prevention: A Harm Reduction Conversation with Dr MJ Milloy

Why isn’t the evidence around supervised injection sites leading to real change? How does cannabis interact with opioid use treatment? In this episode, Dr. M-J Milloy, Interim Director of Research at BCCSU, dives into the data—and the disconnect—between science and policy. We explore gendered and SES experiences of substance use, the link between housing and drug safety, and how research can drive more compassionate public health responses.

March 27, 2025

MAPS Canada presents:

Healing & Harm Reduction in Psychedelics: A Conversation with Erica Siegal

In this episode, MAPS Canada’s Podcast host, Osheen Dayal, talks with Erica Siegal about the ethics, risks, and realities of psychedelic therapy.
Erica is a licensed therapist, harm reduction expert, and the Executive Director of
SHINE Collective, a nonprofit supporting survivors of harm in psychedelic spaces.

February 22, 2025

MAPS Canada Presents:

Cafe Scientifique on Psychedelics and Health Equity

The purpose of this CIHR-funded Cafe Scientifique was to bring together a panel of leading researchers in Canada with expertise on psychedelics and health equity. This hybrid event was held on March 10, 2024 in Vancouver and online with participants across Canada. The program included presentations from panelists: Dr. Erika Dyck, Dr. Monnica Williams, Amy Bartlett and Otis Jasper. This video is a recording of the event, including the panel discussion, a question and answer session, breakout discussions, and an overview of the graphic recording provided by Michelle Buchholz. Kim Haxton moderated the event.

January 13, 2025

MAPS Canada presents:

Catching up with Rick Doblin: FDA's MDMA Decision and What's Next for 2025

Join us online for an exclusive event with Rick Doblin, the founder of MAPS, as we discuss the recent FDA decision on MDMA and what the future holds for 2025. Don’t miss this opportunity to hear firsthand insights from Rick Doblin himself and learn more about the exciting developments in the world of psychedelic research and therapy. Access recording here.

MAPS Canada's SAP CoP Committee presents:

The Special Access Program Tip Sheet

Our SAP Tip Sheet is now live! Learn how you can access Psychedelic-Assisted Therapy (PAT) through Health Canada’s SAP program. You can find tips and templates to streamline your application process!

MAPS Canada's School of Psychedelics presents:

Psychedelics in Canada: Past, Present and Future

Experience the full spectrum of psychedelic knowledge with our complete seminar series. These seven insightful courses cover everything from the historical roots to the modern applications of psychedelics.

BALANCING SAFETY AND ACCESS REPORT

Please read our report on Alberta’s Regulations and service standards, and related recommendations.

MAPS Canada is powered by a large and dedicated group of volunteers!